Your browser doesn't support javascript.
loading
CRISPR/Cas9 for hepatitis B virus infection treatment.
Cai, Bo; Chang, Shixue; Tian, Yuhan; Zhen, Shuai.
Affiliation
  • Cai B; Center of Medical Genetics, Northwest Women's and Children's Hospital, Xi'an, Shaanxi, PR. China.
  • Chang S; Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, PR. China.
  • Tian Y; Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, PR. China.
  • Zhen S; Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, PR. China.
Immun Inflamm Dis ; 11(5): e866, 2023 05.
Article in En | MEDLINE | ID: mdl-37249290

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis B virus / Hepatitis B Limits: Humans Language: En Journal: Immun Inflamm Dis Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis B virus / Hepatitis B Limits: Humans Language: En Journal: Immun Inflamm Dis Year: 2023 Type: Article